Terumo Corporation · TSE:4543

Terumo — Corporate Update (October 2012)

7 slides from Terumo's corporate update, Oct 30, 2012

  1. Slide 1: Direction toward New Mid-term Plan

    Direction toward New Mid-term Plan Terumo Corporation President & Representative Director Yutaro Shintaku October 30, 2012

  2. Slide 2: Direction toward New Mid-term Plan

    Direction toward New Mid-term Plan „ Aim to become a company w/ global presence ¾ Won’t adopt a strategy in “long-term goal FIRST” - 1 trillion yen in 10yrs ¾ Profitable & sustainable growth „ Key initiatives ¾ Re-evaluate the business portfolio ¾ Enrich “minimally invasive” new products pipeline ¾

  3. Slide 3: Enrich "Minimally Invasive Treatment" Products Pipeline

    Enrich “Minimally Invasive Treatment” Products Pipeline „ So far good progress on launching products ¾ Steadily launching growth driver products for current mid-term plan (Nobori, OFDI, Misago) ¾ Misago to be launched ahead of plan (JP) (Original plan: during the fiscal year ending Mar. 2014) „ Prom

  4. Slide 4: Launching New Products in "Minimally Invasive Treatment"

    Launching New Products in “Minimally Invasive Treatment” Strategies Mar. 2015 – Mar. Mar. 2013 Mar. 2014 2017 Nobori Continuously expand （Drug Eluting Stent） Interventional Cardiology License agreement w/ Biosensors New DES business has been extended (EU, Asia) Therapeutic device (US) FRED (EU) JP,

  5. Slide 5: Terumo BCT Status

    Terumo BCT Status „ Sales integration ¾ JP: Market share of automated blood collection system is approaching 50% „ Production Integration and expansion ¾ Acquired site for new factory near Ho Chi Minh City, Vietnam ¾ Full-scale project for production integration initiated „ New products development

  6. Slide 6: Impact of Unrest in China

    Impact of Unrest in China „ Overall, minor impact on 1st Half result. Full-year forecast expected to be achieved. ¾ Minor impact on Cardiac & Vascular business foreseen thru full year ¾ Slight impacts on General Hospital and Blood Management businesses „ Influence on China strategy ¾ Accelerate to s

  7. Slide 7: IR Contact

    IR Contact Terumo Corporation Corporate Communication (IR) Dept. E-mail: [email protected] Among the information that Terumo discloses, the forward-looking statements including financial projections are based upon our assumptions using information available to us at the time and are not i

Terumo — Corporate Update (October 2012) on 6ix